Research on Hypoglycemia Risk in Combination Therapy with Dipeptidyl Peptidase-4 Inhibitors and Other Oral Antidiabetes Medications in Patients with Diabetes Mellitus

碩士 === 中國醫藥大學 === 醫務管理學系碩士班 === 102 === Background and Object: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of drug that can be used for treating diabetes. However, whether administering DPP-4 inhibitors causes the side effect of hypoglycemia has not been determined. The objective of th...

Full description

Bibliographic Details
Main Authors: Yu-Chieh Cheng, 鄭宇傑
Other Authors: 黃光華
Format: Others
Language:zh-TW
Published: 2014
Online Access:http://ndltd.ncl.edu.tw/handle/5rh588

Similar Items